Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide

# Walethmade Bromide ## Overview Walethmade bromide is an anticholinergic medication. ## Primary Indications * Treatment of Parkinson's disease symptoms (tremor, rigidity). * Management of drug-induced extrapyramidal symptoms. ## Adult Dosing * **Parkinson's disease:** Initiate at 1 mg orally once or twice daily, increasing gradually as tolerated. Usual maintenance dose is 1-2 mg three times daily. Maximum dose is generally 6 mg daily, though some sources suggest up to 10 mg daily in select cases. * **Drug-induced extrapyramidal symptoms:** 1-2 mg orally once or twice daily, as needed. ## Pediatric Dosing Dosing in pediatric patients is not well-established. Use with caution and at the lowest effective dose if necessary. ## Dose Adjustments * **Hepatic Impairment:** Use with caution; no specific dose adjustment guidelines are widely established, but reduced doses may be necessary. * **Renal Impairment:** Use with caution; no specific dose adjustment guidelines are widely established, but reduced doses may be necessary. * **Elderly:** Elderly patients may be more susceptible to anticholinergic side effects; start with lower doses and titrate slowly. ## Contraindications * Untreated narrow-angle glaucoma. * Myasthenia gravis. * Obstructive diseases of the genitourinary tract or gastrointestinal tract. * Tachyarrhythmias. * Toxic megacolon. * Known hypersensitivity to walethmade bromide. ## Adverse Effects Common anticholinergic side effects: dry mouth, blurred vision, constipation, urinary retention, confusion, drowsiness, dizziness, nausea, vomiting, tachycardia. Less common: hallucinations, memory impairment, fever, heat prostration. ## Key Drug Interactions * **Other anticholinergics:** Additive anticholinergic effects. * **CNS depressants (e.g., alcohol, sedatives, opioids):** Increased CNS depression. * **MAO inhibitors:** May potentiate anticholinergic effects. * **Amantadine:** Increased risk of anticholinergic and CNS adverse effects. * **Potassium chloride:** Increased risk of gastrointestinal ulceration when taken with solid oral dosage forms. ## Monitoring * Monitor for improvement in Parkinsonian symptoms or extrapyramidal symptoms. * Assess for adverse effects, particularly anticholinergic side effects, cognitive changes, and urinary retention. * Monitor for signs of glaucoma exacerbation in susceptible individuals. ## Clinical Pearls * Gradual titration is essential to minimize side effects. * May be more effective for tremor and rigidity than for bradykinesia. * Can be used adjunctively with levodopa to manage Parkinson's disease. * Educate patients on potential side effects, especially dry mouth (recommend sugar-free candy or gum) and constipation (recommend increased fiber and fluids). *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and guidelines, and exercise your professional judgment when making treatment decisions. Local protocols may vary.